Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05898_nanopub.RAemzVOg7SZ000G8i9bgztGXyJ9pH6bLdK-dXBYRTDNMw#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05898 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05898 label "CERE-110 [drugbank:DB05898]" assertion.
- drugbank:DB05898 seeAlso DB05898 assertion.
- drugbank:DB05898 description "CERE-110 is a gene-therapy product that involves in vivo delivery of nerve growth factor (NGF) genes through an adeno-associated viral vector (AAV) delivery system. This drug is developed by Ceregene and currently under phase I of clinical trial." assertion.
- drugbank:DB05898 identifier "drugbank:DB05898" assertion.
- drugbank:DB05898 title "CERE-110" assertion.
- drugbank:DB05898 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05898 drugbank_vocabulary:drugbank-id "DB05898" assertion.
- drugbank:DB05898 bio2rdf_vocabulary:x-identifiers.org DB05898 assertion.
- drugbank:DB05898 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05898" assertion.
- drugbank:DB05898 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05898 bio2rdf_vocabulary:identifier "DB05898" assertion.